Work

Exenatide-Associated Ischemic Renal Failure

Year: 2009
Type: article
Study design: Case Report
Abstract: Exenatide is a synthetic peptide that belongs to a new class of antidiabetes agents known as incretin mimetics. Like the endogenous incretin hormone glucagon-like peptide 1 (GLP-1), exenatide effectively lowers blood glucose levels by stimulating insulin release, inhibiting glucagon secretion, and delaying gastric emptying. Nausea and vomiting are the most common adverse reactions, which lead to discontinuation in as many as 14% of patients in one study (1). We report on four patients (three male and one female; age 52–73 years) with exenatide-associated renal failure who presented with nausea, vomiting, or decreased fluid intake. All patients had type 2 diabetes with or without mild microalbuminuria and hypertension. They were taking …
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W1971478725
FWCI: 6.133
Cites: 4
Cited by: 99
Related to: 10